Ketamine Infusion for Adolescent Depression and Anxiety
Status:
Completed
Trial end date:
2019-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the tolerability and short-term efficacy of a
single ketamine infusion for the treatment of adolescents with 1) medication-refractory major
depressive disorder (MDD) and/or 2) medication-refractory anxiety disorders (social anxiety
disorder, panic disorder, generalized anxiety disorder and/or separation anxiety disorder).